Skip to main content
Download PDF

Protective behavior and SARS-CoV-2 infection risk in the population – Results from the Gutenberg COVID-19 study

BMC Public Health volume 22, Article number: 1993 (2022) Cite this article

Abstract

Background

During the SARS-CoV-2 pandemic, preventive measures like physical distancing, wearing face masks, and hand hygiene have been widely applied to mitigate viral transmission. Beyond increasing vaccination coverage, preventive measures remain urgently needed. The aim of the present project was to assess the effect of protective behavior on SARS-CoV-2 infection risk in the population.

Methods

Data of the Gutenberg COVID-19 Study (GCS), a prospective cohort study with a representative population-based sample, were analyzed. SARS-CoV-2 infections were identified by sequential sampling of biomaterial, which was analyzed by RT-qPCR and two antibody immunoassays. Self-reported COVID-19 test results were additionally considered. Information on protective behavior including physical distancing, wearing face masks, and hand hygiene was collected via serial questionnaire-based assessments. To estimate adjusted prevalence ratios and hazard ratios, robust Poisson regression and Cox regression were applied.

Results

In total, 10,250 participants were enrolled (median age 56.9 [43.3/68.6] years, 50.8% females). Adherence to preventive measures was moderate for physical distancing (48.3%), while the use of face masks (91.5%) and the frequency of handwashing (75.0%) were high. Physical distancing appeared to be a protective factor with respect to SARS-CoV-2 infection risk independent of sociodemographic characteristics and individual pandemic-related behavior (prevalence ratio [PR] = 0.77, 95% confidence interval [CI] 0.62–0.96). A protective association between wearing face masks and SARS-CoV-2 transmission was identified (PR = 0.73, 95% CI 0.55–0.96). However, the protective effect declined after controlling for potential confounding factors (PR = 0.96, 95% CI 0.68–1.36). For handwashing, this investigation did not find a beneficial impact. The adherence to protective behavior was not affected by previous SARS-CoV-2 infection or immunization against COVID-19.

Conclusion

The present study suggests primarily a preventive impact of physical distancing of 1.5 m, but also of wearing face masks on SARS-CoV-2 infections, supporting their widespread implementation. The proper fit and use of face masks are crucial for effectively mitigating the spread of SARS-CoV-2 in the population.

Peer Review reports

Background

During the ongoing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) pandemic, preventive measures such as physical distancing, wearing face masks, and hand hygiene have been widely applied to mitigate the burden of coronavirus disease 19 (COVID-19). Countries have taken specific measures depending on the course of the pandemic and the prevailing variant, including closing public life during periods of high incidence of SARS-CoV-2. A study using a database of global pandemic measures showed that countries’ responses to the pandemic were similar in the early post-outbreak period and varied thereafter in 2020 [1]. In Germany, the government recommended keeping physical distance from others, limiting personal contact, and washing hands thoroughly from the beginning of the pandemic. As of the end of April 2020, it was mandatory to wear a face mask indoors and on public transportation [2, 3]. Although COVID-19 vaccination programs have been successfully implemented in most countries, protective behavior remains urgently necessary since vaccination coverage rates are not complete and transmission of SARS-CoV-2 infection remains possible despite vaccination [4,5,6].

International evidence predominantly suggests that preventive measures such as keeping distance from others, closing public facilities, and use of face masks are effective in reducing viral transmission [7,8,9,10,11]. However, evidence on protective measures for prevention of SARS-CoV-2 is mostly derived from simulation or ecological studies [12,13,14,15]. Besides, systematic reviews considered research on the impact of wearing face masks as insufficient, particularly in community settings [10, 16]. Hence, there is still a paucity of evidence on this topic and results are inconclusive. More generally, studies replicating the findings of personal protective behavior and its impact on mitigating SARS-CoV-2 transmission with large population cohorts including individual-level data are limited in literature.

Hence, the present study aimed to investigate the effect of protective behavior, including physical distancing, wearing face masks, and hand hygiene on SARS-CoV-2 infection risk in the population by making use of the Gutenberg COVID-19 Study: a large prospective cohort of individuals sampled from the population during the second and third wave of the SARS-CoV-2 pandemic in Germany in a representative manner.

Methods

Study design and population sample

The data used to address the objective are part of the Gutenberg COVID-19 Study (GCS), a population-based prospective cohort study. This study includes a representative sample of individuals aged 25 to 88 years which was randomly drawn by the regional registration offices. The sample was stratified in a 1:1 manner by sex and place of residence (City of Mainz/District of Mainz-Bingen), as well as for age decades. Apart from residence in the City of Mainz or the District of Mainz-Bingen, ability to visit the study center, and sufficient understanding of the German language, no inclusion or exclusion criteria were defined. The baseline examination was conducted from October 2020 to April 2021, and the follow-up assessment approximately four months later from March 2021 to June 2021. At both baseline and follow-up, a computer-assisted personal interview was performed and biomaterial was sampled at the study center. Additionally, participants were sent questionnaires in advance to return to the study site. In addition to biomaterial sampling, the highly granular data collection included SARS-CoV-2 infection, symptoms, protective behaviors, comorbidities, health-related risk factors, medical care, psychosocial burden, and lifestyle and environmental factors. Regarding demographic characteristics, detailed data on age, sex, marital status, children, education, occupation, migration background, and working and living conditions were collected as part of the study. The GCS was designed, conducted, and analyzed in accordance with the Declaration of Helsinki and Good Epidemiological Practice.

Identification of SARS-CoV-2 infections in the sample

SARS-CoV-2 infections were identified using a multimodal approach in which biomaterial was collected at baseline and follow-up. To identify acute infection, throat swabs were analyzed by quantitative reverse transcription polymerase chain reaction (RT-qPCR) using the Light Mix SarbecoV E-gene (plus EAV control) and RdRP-gene (TIB Molbiol, Germany). The methods used for RT-qPCR have been described elsewhere (laboratory 2) [17]. EDTA plasma samples were analyzed for circulating antibodies to the SARS-CoV-2 nucleocapsid with a qualitative microparticle chemiluminescent immunoassay (Architect SARS-CoV-2 IgG, Abbott, Germany) with a threshold of 1.4 relative light units and second, a qualitative microparticle electro-chemiluminescence immunoassay (Elecsys Anti-SARS-CoV-2 Pan-Ig, Roche, Germany) with a cutoff index of 0.8. Any self-reported PCR results were additionally included which were collected retrospectively via a computer-assisted personal interview and continuously via a weekly smartphone-app survey. Individuals were considered infected if any of these measurements were positive. Detailed information on sample preprocessing and storage is provided in the Supplementary Appendix.

Assessment of protective behavior

Information on protective behavior was collected twice, at baseline and follow-up, using questionnaires. In terms of physical distance, study participants were asked how often they maintained a minimum distance of 1.5 m from contacts outside their household. Regarding the use of face masks, they were asked how often they wore masks (surgical masks, N95/FFP2 respirators, or self-made masks without differentiation) e.g., while shopping, working, or on public transportation. For both questions, answer options ranged from “never” to “always/almost always” on a 5-point Likert scale. Compliance with physical distancing and wearing masks was defined when participants indicated they adhered “almost always/always”. Frequency of hand washing was classified according to published literature with 0–5 times per day as rarely, 6–10 times as moderate, and > 10 times as frequent [11, 18]. Adherence to hand hygiene was defined when handwashing was reported as at least moderate.

Statistical analysis

Continuous variables were summarized by median and interquartile range. Absolute and relative frequencies were calculated for categorical variables.

Prior to analysis, a directed acyclic graph (DAG) was generated using DAGitty software [19]. The minimum adjustment set based on the DAG comprised age, sex, socioeconomic status (SES), time of enrollment into study, occupational status, and pandemic-related behaviors (COVID-19 vaccination status, COVID-19 contact in the past two weeks, participation in gatherings, travel in the past two weeks, hand disinfection, and avoidance of shaking hands, attending gatherings, and hugging of people in direct surrounding area).

Robust Poisson regression models with adjustment for potential confounders were applied to evaluate the effect of protective behavior on SARS-CoV-2 infection risk. A time-to-event analysis was performed to investigate the risk of incident SARS-CoV-2 infection as a function of protective behavior. Kaplan-Meier estimators were used to generate cumulative incidence plots, and log-rank tests to test for differences between curves. Univariate and multivariable Cox regression models were used to estimate the effect of protective behavior on incident SARS-CoV-2 infections from January 2020 to June 2021. Before October 2020 (i.e., before the study start), only retrospectively collected self-reported infections were considered. Participants without infection date, who were primarily individuals identified as infected with SARS-CoV-2 via positive antibody measurements only, were excluded in time-to-event analysis. Finally, an interaction analysis was performed within an adjusted robust Poisson regression to examine whether the effect of protective behavior on SARS-CoV-2 infections was moderated by age. Protective behavior at baseline was considered as exposure to infection and was assumed not to change. Complete case analyses were performed for all regression models.

In this exploratory approach, p-values were used as continuous measures of statistical evidence of an effect. All analyses were carried out using the software package R version 4.1.0 [20].

Results

Characteristics of the population sample

A total of 10,250 participants with a median age of 56.9 (43.3/68.6) years and a balanced sex ratio (50.8% female participants) were enrolled in the GCS. The majority were Caucasian (99.3%). Sociodemographic characteristics and pandemic-related behavior of the sample stratified by sex are shown in Table 1. Women were slightly younger than men and more likely employed. Conversely, women had lower SES compared with males. Adherence to physical distancing was moderate, while use of face masks and frequency of handwashing were high, which was true for both sexes. Women were more likely than men to engage in protective behaviors and showed less travel activities and higher COVID-19 vaccination rates.

Table 1 Characteristics of the population sample
Full size table

Prevalence and incidence of SARS-CoV-2 infection in relation to adherence to protective measures

Among individuals who never or rarely maintained the minimum distance, the prevalence of SARS-CoV-2 infection was approximately twice that of persons who almost always or always maintained a physical distance (Fig. 1, Panel A). A similar trend was observed for face mask use: Substantially fewer infections were found in individuals who almost always or always wore a face mask than in individuals who did not (Fig. 1, Panel B). Regarding hand hygiene, no relevant protective association with SARS-CoV-2 infection risk was observed (Fig. 1, Panel C).

Fig. 1
figure 1

SARS-CoV-2 infection risk according to protective behavior in the population sample. The figure illustrates the prevalence of SARS-CoV-2 infection as a function of physical distancing (n = 9,664), use of face masks (n = 9,678), and hand hygiene (n = 9,326), respectively.

Full size image
Fig. 2
figure 2

Incident SARS-CoV-2 infections corresponding to protective behavior from January 2020 to June 2021. This figure presents the cumulative incidence of SARS-CoV-2 infections in the population sample corresponding to the adherence to physical distancing (n = 9,344), use of face masks (n = 9,362), and hand hygiene (n = 9,016), respectively. Prior to October 2020 (i.e., the start of the GCS), only self-reported positive PCR tests were considered. Individuals with antibody positivity only were excluded

Full size image

The estimated cumulative incidence of SARS-CoV-2 infections in the study region between January 2020 to June 2021 is shown in Fig. 2, assuming no change in protective behavior, which was so confirmed in the study cohort. While individuals who adhered to physical distancing had a cumulative incidence of 1.3% after 18 months, a cumulative incidence of 2.6% was observed among non-adherent individuals (log-rank P = 0.00037, Fig. 2, Panel A). Regarding the use of face masks (log-rank P = 0.75) and hand hygiene (log-rank P = 0.66), no relevant differences in the incidence of SARS-CoV-2 infection were observed in adherent and non-adherent individuals (Fig. 2, Panel B and C).

Estimating the impact of protective behaviors on SARS-CoV-2 infection risk

Physical distancing (prevalence ratio [PR] = 0.71, 95% confidence interval [CI] 0.59–0.85) and use of face masks (PR = 0.73, 95% CI 0.55–0.96) were found to have a protective effect on reducing the risk of SARS-CoV-2 infections in univariate robust Poisson regression. While physical distancing remained an independent protective factor associated with a 23% (PR = 0.77, 95% CI 0.62–0.96) reduction in SARS-CoV-2 infection risk even after adjusting for time of entry into the study, sociodemographic characteristics, and individual pandemic-related behaviors, the estimated effect of wearing face masks was smaller. No beneficial effect on SARS-CoV-2 infection risk was observed regarding the frequency of hand washing (Table 2).

Cox regression models estimated that physical distancing reduced infection risk by 44% (hazard ratio [HR] = 0.66, 95% CI 0.40–0.77). However, after adjustment for time of enrolment into study, demographic characteristics, and pandemic-related behaviors, the effect size was slightly attenuated. Regarding the use of face masks and hand hygiene, there was no evidence of a beneficial impact on the incidence of SARS-CoV-2 infections in univariate or adjusted models (Supplemental Table 1).

To evaluate the impact of protective behavior during the time course of the COVID-19 pandemic, analyses were stratified by the second and third SARS-CoV-2 infection wave in Germany. Results did not differ significantly during the pandemic (Supplemental Fig. 1). The effect of protective behaviors on SARS-CoV-2 infection risk did also not meaningfully differ between time periods when either the wild type or alpha variant was dominant in Germany (Supplemental Table 2). Finally, an interaction analysis to explore whether older individuals, a particularly vulnerable group at risk for a severe course of COVID-19, benefited disproportionately from protective behavior revealed no moderation by age (P for interaction = 0.81; Supplemental Fig. 2).

Table 2 Effect of protective behavior on SARS-CoV-2 infection risk in the population sample
Full size table

Protective behavior before and after infection or vaccination

Since protective behavior was assumed to be stable during the pandemic, the development of protective behavior was explored as a function of SARS-CoV-2 infection and COVID-19 vaccination. Adherence to preventive measures in individuals before and after SARS-CoV-2 infection is illustrated in Fig. 3, Panel A, and indicates virtually no difference. Immunization with at least two COVID-19 vaccines also did not appear to affect physical distance maintenance, use of face masks, or hand hygiene (Fig. 3, Panel B).

Fig. 3
figure 3

Development of protective behavior before and after infection (Panel A) and vaccination (Panel B). Panel A illustrates the change in protective behavior among individuals before and after SARS-CoV-2 infection. Panel B displays the change in protective behavior before and after vaccination with COVID-19 vaccines

Full size image

Discussion

The results of this population-based prospective cohort study suggest a preventive effect of physical distancing of 1.5 m and wearing face masks in reducing SARS-CoV-2 infection risk. No beneficial effect was identified for the adherence to hand hygiene measures. The present results indicate similar effects of protective behaviors on viral transmission during the second and third wave of the COVID-19 pandemic, and that these effects applied similarly to individuals of all ages. Interestingly, the adherence to preventive measures was not substantially affected by previous SARS-CoV-2 infection or basic immunization against COVID-19. These findings add to the growing body of evidence on the effect of preventive measures in mitigating the spread of SARS-CoV-2 by showing the impact of protective behaviors with individual-level data of a representative cohort.

Physical distancing

Consistent with the findings of this study, a large population-based study of 198,022 participants in the US identified physical distancing to reduce SARS-CoV-2 infection risk among individuals living in communities with high adherence to social distancing [8]. A study investigating the effects of various non-pharmaceutical interventions on SARS-CoV-2 transmission in Europe provided further evidence that physical distancing measures are highly effective [21]. A meta-analysis of observational studies additionally found a dose-response relationship between every additional meter of physical distance maintained and reduction in infection risk with SARS-CoV, SARS-CoV-2, and MERS-CoV [10]. In the current study, the effect of physical distancing declined in Cox regression models after adjustment for potential confounders. However, individuals identified as infected only by antibody positivity were excluded from this time-to-event analysis since the date of infection was not known. This reduced the sample size of infected individuals and thus the power to detect a statistically relevant impact.

Wearing face masks

Regarding the use of face masks, a meta-analysis suggested that face masks largely reduce infection risk of various coronaviruses [10]. However, the certainty of evidence was considered low according to the GRADE guideline, and specifically for SARS-CoV-2, only studies in healthcare settings were considered. In case of community settings, a randomized controlled trial showed that the recommendation to wear face masks did not result in increased protection against SARS-CoV-2 among mask wearers in either the intention-to-treat or per protocol analyses [22]. A systematic review on population-level concluded that using face masks may reduce SARS-CoV-2 infections [23]. However, major limitations were that most of the reviewed studies used mask mandates as exposure, that information on adherence was lacking, and that the effect of other protective measures was mostly not considered. A population-based study further indicated that face mask use reduced SARS-CoV-2 infection risk also among individuals living in communities with poor social distancing [8]. Interestingly, the protective effect against infection was larger in individuals reporting wearing a face mask sometimes (HR = 0.27, 95% CI 0.18–0.41) than among individuals who always wore a mask (HR = 0.38, 95% CI 0.31–0.46). Regarding the effect of masks on transmission of other acute respiratory viruses, a Cochrane review of interventional randomized controlled trials revealed that medical or surgical masks resulted in little or no difference in infection with laboratory-confirmed influenza compared with no masks [24]. This finding was derived from one trial in healthcare workers and five studies in community settings. Similarly, pooled data of four trials in the healthcare sector and one in a household setting additionally indicated no or little difference between N95/FFP2 respirators and medical or surgical masks with respect to infection with laboratory-confirmed influenza. Both findings were considered as moderate-certainty evidence. In a simulation study, the conflicting findings in the literature regarding the efficacy of face masks were explained by the fact that the protective effect depends on airborne virus abundance [25].

Given the current results, adherence to use of face masks was very high in this cohort, limiting the power to detect differences and thus may not reflect the protective effect of face masks. Particularly among women, only one infected individual was identified who never or rarely wore a mask, as a total of only 10 women reported never or rarely wearing a face mask. Hence, after adjustment for sex, the effect of masks was neutralized. Besides, no differentiation was made between the different type of masks (e.g., surgical masks, N95/FFP2 respirators, or self-made masks). Considering the recommendation in the study region Rhineland-Palatinate, it is expected that participants mainly wore surgical masks. Moreover, since the regulation to exclusively wear medical masks became effective on January 25, 2021 in the study region, self-made or cloth masks may have been included in the analyses [26, 27]. The filtration efficacy of these masks is highly dependent on material and number of layers [28], but is still less effective than surgical masks or N95/FFP2 protectors [29]. FFP2 masks have been shown to be the most effective mask with respect to SARS-CoV-2 infection risk [30]. However, regardless of the type of face mask, efficacy strongly depends on the proper fit of the mask. For instance, FFP2 masks whose fit was adjusted with tape around the nose showed the least inward leakage of aerosols. Generally, face masks are medical disposable products that should be changed regularly, especially after moisture intrusion. While FFP2 masks are more resistant and may be reused for private use [31], the reuse of surgical masks is not recommended [32]. The majority of individuals may not sufficiently adjust or appropriately change their face masks, particularly for daily activities such as grocery shopping, which affects the protective performance of masks. The non-distinction of the type of face masks in this study and the reflection of this everyday behavior in the GCS due to its study design may provide additional explanations for the observed result related to face masks and SARS-CoV-2 infection risk.

Hand hygiene

Hand hygiene has not been identified as a protective factor in reducing SARS-CoV-2 viral transmission. SARS-CoV-2 is primarily transmitted via respiratory droplets and aerosol particles [33, 34], providing a possible explanation for the observed non-protective effect. Consistent with these findings, results from a Swedish population-based study using a similar categorization of handwashing frequency showed no reduced risk of acute respiratory tract infections or influenza-like illness [35]. In contrast, another prospective cohort study suggested a positive effect of moderate frequency of hand washing on acquisition of seasonal coronavirus [11]. However, high frequency of hand hygiene did not result in reduced infection risk and the analysis did not consider other factors of personal risk behavior. Because the evidence on handwashing and influenza-like illness is inconclusive and the evidence on the effect of hand hygiene specifically on SARS-CoV-2 is limited, further research is needed to derive evidence-based recommendations.

Lastly, a simulation study suggested that single preventive measures are not sufficient to substantially reduce highly contagious variants of SARS-CoV-2, such as the Delta or Omicron variants [36]. However, the combination of several measures, such as physical distancing, wearing face masks, frequent testing, and improving the ventilation of rooms, synergistically reduced the reproduction number, considering different scenarios of compliance and vaccination rates. This highlights the importance of implementing and adhering to various public health measures to effectively contain viral transmission.

Strengths and limitations

The major strength of the present investigation is the large, representative, and comprehensively characterized population sample, which allows adjustment for other public health measures and individual risk behaviors (Fig. 4). Beyond the use of two immunoassays covering different antibody spectra, the GCS included individuals unknowingly infected with SARS-CoV-2, a group of individuals usually not represented or underrepresented in studies investigating SARS-CoV-2. However, some limitations should be noted. Protective behavior at baseline was considered exposure to infection throughout the study period. Therefore, it was assumed that individual protective behavior would not change during the pandemic, and this was demonstrated in the study. In addition, adherence to preventive measures was only self-reported, which could be influenced by recall bias or social desirability [11]. Nevertheless, in the absence of objective measurements for this type of information, self-reported data are currently the best data source, despite the limitations in objectivity.

Fig. 4
figure 4

Directed acyclic graph (DAG) of the association between protective behavior and SARS-CoV-2 infection risk. Green: exposure; blue with I: outcome; grey: unobserved variable, blue: ancestor of outcome; red: ancestor of exposure and outcome

Full size image

Conclusion

The present study suggests physical distancing and wearing face masks to be protective with regard to SARS-CoV-2 infection risk in the general population, supporting their widespread application. The proper fit and use of face masks, however, is extremely important to effectively contain viral transmission. Hand hygiene did not reduce the risk of infection with SARS-CoV-2. Since none of these measures provide complete protection against SARS-CoV-2, other measures such as vaccination and comprehensive testing are still needed to mitigate the spread of SARS-CoV-2. Especially in light of emerging highly contagious variants, such as Omicron, synergistic effects of multiple protective measures are required.

Data Availability

With regard to sharing data of the GCS, study documents, informed consent of the participants, and the approval of the responsible ethics committee do not allow publicly sharing the data according to regulations for data protection (EU General Data Protection Regulation). The data used during the current study are available at the local database from the corresponding author upon request.

Abbreviations

CI:

Confidence interval.

COVID-19:

Coronavirus disease 2019.

DAG:

Directed Acyclic Graph.

GCS:

Gutenberg COVID-19 Study.

GRADE:

Grading of Recommendations Assessment, Development and Evaluation.

HR:

Hazard ratio.

IQR:

Interquartile range.

MERS-CoV:

Middle East respiratory syndrome coronavirus.

PR:

Prevalence ratio.

RT-qPCR:

Quantitative reverse transcription polymerase chain reaction.

SARS-CoV:

Severe acute respiratory syndrome coronavirus.

SARS-CoV-2:

Severe acute respiratory syndrome coronavirus 2.

SES:

Socioeconomic status.

References

  1. Hale T, Angrist N, Goldszmidt R, Kira B, Petherick A, Phillips T, et al. A global panel database of pandemic policies (Oxford COVID-19 Government Response Tracker). Nat Hum Behav. 2021;5(4):529–38.

    Article  PubMed  Google Scholar 

  2. Bundesregierung. Telefonschaltkonferenz der Bundeskanzerlin mit den Regierungschefinnen und Regierungschefs der Länder am 15. April 2020. Beschluss: Bundesregierung; 2020 [Available from: https://www.bundesregierung.de/resource/blob/973812/1744226/bcf47533c99dc84216eded8772e803d4/2020-04-15-beschluss-bund-laender-data.pdf.

  3. Landesregierung Rheinland-Pfalz. Fünfte Corona-Bekämpfungsverordnung Rheinland-Pfalz (5. CoBeLVO) vom 30. April 2020: Landesregierung Rheinland-Pfalz; 2020 [Available from: https://corona.rlp.de/fileadmin/rlp-stk/pdf-Dateien/Corona/5._Corona-Bekaempfungsverordnung_Rheinland-Pfalz.pdf.

  4. Love J, Keegan LT, Angulo FJ, McLaughlin JM, Shea KM, Swerdlow DL, et al. Continued need for non-pharmaceutical interventions after COVID-19 vaccination in long-term-care facilities. Sci Rep. 2021;11(1):18093.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Hassan W, Kazmi SK, Tahir MJ, Ullah I, Royan HA, Fahriani M, et al. Global acceptance and hesitancy of COVID-19 vaccination: A narrative review. Narra J. 2021;1(3).

  6. Surawan DP, Sumohadi D, Budhitresna AAG, Lestari PP, Dewi K, Wikananda W, et al. Titer disparity of anti-Spike receptor binding domain SARS-CoV-2 antibody between vaccinated and naturally infected individuals. Narra J. 2022;2(1).

  7. Brauner JM, Mindermann S, Sharma M, Johnston D, Salvatier J, Gavenčiak T, et al. Inferring the effectiveness of government interventions against COVID-19. Science. 2021;371(6531):eabd9338.

    Article  CAS  PubMed  Google Scholar 

  8. Kwon S, Joshi AD, Lo C-H, Drew DA, Nguyen LH, Guo C-G, et al. Association of social distancing and face mask use with risk of COVID-19. Nat Commun. 2021;12(1):3737.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Rader B, White LF, Burns MR, Chen J, Brilliant J, Cohen J, et al. Mask-wearing and control of SARS-CoV-2 transmission in the USA: a cross-sectional study. Lancet Digit Health. 2021;3(3):e148-e57.

    Google Scholar 

  10. Chu DK, Akl EA, Duda S, Solo K, Yaacoub S, Schünemann HJ, et al. Physical distancing, face masks, and eye protection to prevent person-to-person transmission of SARS-CoV-2 and COVID-19: a systematic review and meta-analysis. Lancet. 2020;395(10242):1973–87.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  11. Beale S, Johnson AM, Zambon M, Flu Watch G, Hayward AC, Fragaszy EB. Hand Hygiene Practices and the Risk of Human Coronavirus Infections in a UK Community Cohort. Wellcome Open Res. 2021;5:98.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Mitze T, Kosfeld R, Rode J, Wälde K. Face masks considerably reduce COVID-19 cases in Germany. PNAS. 2020;117(51):32293–301.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  13. Koh WC, Naing L, Wong J. Estimating the impact of physical distancing measures in containing COVID-19: an empirical analysis. Int J Infect Dis. 2020;100:42–9.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. Chang S, Pierson E, Koh PW, Gerardin J, Redbird B, Grusky D, et al. Mobility network models of COVID-19 explain inequities and inform reopening. Nature. 2021;589(7840):82–7.

    Article  CAS  PubMed  Google Scholar 

  15. Tsai AC, Harling G, Reynolds Z, Gilbert RF, Siedner MJ. Coronavirus Disease 2019 (COVID-19) Transmission in the United States Before Versus After Relaxation of Statewide Social Distancing Measures. Clin Infect Dis. 2020;73(Supplement_2):120-S6.

    Google Scholar 

  16. Chou R, Dana T, Jungbauer R. Update Alert 6: Masks for Prevention of Respiratory Virus Infections, Including SARS-CoV-2, in Health Care and Community Settings. Ann Intern Med. 2021;174(9):W68-W.

    Article  Google Scholar 

  17. Hauser F, Sprinzl MF, Dreis KJ, Renzaho A, Youhanen S, Kremer WM, et al. Evaluation of a laboratory-based high-throughput SARS-CoV-2 antigen assay for non-COVID-19 patient screening at hospital admission. Med Microbiol Immunol. 2021;210(2–3):165–71.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Castilla J, Godoy P, Domínguez Á, Martín V, Delgado-Rodríguez M, Martínez-Baz I, et al. Risk factors and effectiveness of preventive measures against influenza in the community. Influenza Other Respir Viruses. 2013;7(2):177–83.

    Article  PubMed  Google Scholar 

  19. Textor J, Van der Zander B, Gilthorpe MK, Liskiewicz M, Ellison GTT. Robust causal inference using directed acyclic graphs: the R package ‘dagitty’. Int J Epidemiol. 2016;45(6):1887.189.

    Google Scholar 

  20. R Core Team. R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria URL https://wwwR-projectorg/. 2020.

  21. Flaxman S, Mishra S, Gandy A, Unwin HJT, Mellan TA, Coupland H, et al. Estimating the effects of non-pharmaceutical interventions on COVID-19 in Europe. Nature. 2020;584(7820):257–61.

    Article  CAS  PubMed  Google Scholar 

  22. Bundgaard H, Bundgaard JS, Raaschou-Pedersen DET, von Buchwald C, Todsen T, Norsk JB, et al. Effectiveness of Adding a Mask Recommendation to Other Public Health Measures to Prevent SARS-CoV-2 Infection in Danish Mask Wearers: A Randomized Controlled Trial. Ann Intern Med. 2021;174(3):335–43.

    Article  PubMed  Google Scholar 

  23. Ford N, Holmer HK, Chou R, Villeneuve PJ, Baller A, Van Kerkhove M, et al. Mask use in community settings in the context of COVID-19: A systematic review of ecological data. EClinicalMedicine. 2021;38.

  24. Jefferson T, Del Mar CB, Dooley L, Ferroni E, Al-Ansary LA, Bawazeer GA, et al. Physical interventions to interrupt or reduce the spread of respiratory viruses. Cochrane Database Syst Rev. 2020;11(11):Cd006207.

    PubMed  Google Scholar 

  25. Cheng Y, Ma N, Witt C, Rapp S, Wild PS, Andreae MO, et al. Face masks effectively limit the probability of SARS-CoV-2 transmission. Science. 2021.

  26. Bundesregierung. Videoschaltkonferenz der Bundeskanzlerin mit den Regierungschefinnen und Regierungschefs der Länder am 19. Januar 2021. Beschluss. 2021 [Available from: https://www.bundesregierung.de/resource/blob/974430/1840868/1c68fcd2008b53cf12691162bf20626f/2021-01-19-mpk-data.pdf?download=1.

  27. Landesregierung Rheinland-Pfalz. Änderungsverordnung zur Änderung der Fünfzehnten Corona-Bekämpfungsverordnung Rheinland-Pfalz vom 22. Januar 2021 2021 [Available from: https://corona.rlp.de/fileadmin/rlp-stk/pdf-Dateien/Corona/15._CoBeLVO/AEnderungsVO_22.01.21/1._AEndVO_15._CoBeLVO_Begruendung.pdf.

  28. Maher B, Chavez R, Tomaz GCQ, Nguyen T, Hassan Y. A fluid mechanics explanation of the effectiveness of common materials for respiratory masks. Int J Infect Dis. 2020;99:505–13.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  29. Drewnick F, Pikmann J, Fachinger F, Moormann L, Sprang F, Borrmann S. Aerosol filtration efficiency of household materials for homemade face masks: Influence of material properties, particle size, particle electrical charge, face velocity, and leaks. Aerosol Sci Technol. 2021;55(1):63–79.

    Article  CAS  Google Scholar 

  30. Bagheri G, Thiede B, Hejazi B, Schlenczek O, Bodenschatz E. An upper bound on one-to-one exposure to infectious human respiratory particles. PNAS. 2021;118:49.

    Article  Google Scholar 

  31. Peters A, Lotfinejad N, Palomo R, Zingg W, Parneix P, Ney H, et al. Decontaminating N95/FFP2 masks for reuse during the COVID-19 epidemic: a systematic review. Antimicrob Resist Infect Control. 2021;10(1):144.

    Article  PubMed  PubMed Central  Google Scholar 

  32. Bundesinstitut für Arzneimittel und Medizinprodukte. Hinweise des BfArM zur Verwendung von Mund-Nasen-Bedeckungen, medizinischen Gesichtsmasken sowie partikelfiltrierenden Halbmasken (FFP-Masken) 2022 [Available from: https://www.bfarm.de/SharedDocs/Risikoinformationen/Medizinprodukte/DE/schutzmasken.html?nn=844982.

  33. Cevik M, Kuppalli K, Kindrachuk J, Peiris M. Virology, transmission, and pathogenesis of SARS-CoV-2. BMJ. 2020;371:m3862.

    Article  PubMed  Google Scholar 

  34. Hui KPY, Cheung MC, Perera R, Ng KC, Bui CHT, Ho JCW, et al. Tropism, replication competence, and innate immune responses of the coronavirus SARS-CoV-2 in human respiratory tract and conjunctiva: an analysis in ex-vivo and in-vitro cultures. Lancet Respir Med. 2020;8(7):687–95.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Merk H, Kühlmann-Berenzon S, Linde A, Nyrén O. Associations of hand-washing frequency with incidence of acute respiratory tract infection and influenza-like illness in adults: a population-based study in Sweden. BMC Infect Dis. 2014;14:509.

    Article  PubMed  PubMed Central  Google Scholar 

  36. Su H, Cheng Y, Witt C, Ma N, Pöschl U. Synergetic measures to contain highly transmissible variants of SARS-CoV-2. medRxiv. 2021:2021.11.24.21266824.

Download references

Acknowledgements

We are indebted to all study participants of the Gutenberg COVID-19 Study for their contribution. We thank all study staff and researchers involved in the planning and conduct of the study. Part of this work is part of the doctoral thesis of Rieke Baumkötter.

Funding

The study was funded by the European Regional Development Fund and the Ministry of Science and Health of the State of Rhineland-Palatinate (EFRE/REACT-EU, Grant No. 84007232 and No. 84009735); by the ReALity Initiative of the Life Sciences of the Johannes Gutenberg University Mainz for the establishment of a cell bank; and by the National University Medicine Research Network on Covid-19 (”NaFoUniMedCovid19”, Grant No. 01KX2021) B-FAST for the topics “poor living conditions” and “working conditions” and their association with COVID-19 in the population.

Biomaterials were stored at the BioBank Mainz of the University Medical Center Mainz.

Open Access funding enabled and organized by Projekt DEAL.

Author information

Authors and Affiliations

  1. Preventive Cardiology and Preventive Medicine, Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Langenbeckstr. 1, 55131, Mainz, Germany

    Rieke Baumkötter, Simge Yilmaz, Daniela Zahn, Katharina Fenzl, Jürgen H. Prochaska & Philipp S. Wild

  2. German Center for Cardiovascular Research (DZHK), partner site Rhine Main, Mainz, Germany

    Rieke Baumkötter, Simge Yilmaz, Jürgen H. Prochaska, Karl J. Lackner, Thomas Münzel & Philipp S. Wild

  3. Center for Thrombosis and Hemostasis (CTH), University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

    Jürgen H. Prochaska & Philipp S. Wild

  4. Institute of Clinical Chemistry and Laboratory Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

    Heidi Rossmann & Karl J. Lackner

  5. Institute of Medical Biostatistics, Epidemiology and Informatics, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

    Irene Schmidtmann

  6. Department of Ophthalmology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

    Alexander K. Schuster

  7. Department of Psychosomatic Medicine, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

    Manfred E. Beutel

  8. Cardiology I, Center for Cardiology, University Medical Center of the Johannes Gutenberg University Mainz, Mainz, Germany

    Thomas Münzel

  9. Institute of Molecular Biology (IMB), Mainz, Germany

    Philipp S. Wild

Authors
  1. Rieke Baumkötter
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Simge Yilmaz
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Daniela Zahn
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Katharina Fenzl
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Jürgen H. Prochaska
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Heidi Rossmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Irene Schmidtmann
    View author publications

    You can also search for this author in PubMed Google Scholar

  8. Alexander K. Schuster
    View author publications

    You can also search for this author in PubMed Google Scholar

  9. Manfred E. Beutel
    View author publications

    You can also search for this author in PubMed Google Scholar

  10. Karl J. Lackner
    View author publications

    You can also search for this author in PubMed Google Scholar

  11. Thomas Münzel
    View author publications

    You can also search for this author in PubMed Google Scholar

  12. Philipp S. Wild
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

Study concept and design: P.S.W., D.Z., J.H.P., M.E.B., K.J.L., I.S., A.K.S., T.M. Acquisition and analysis: all authors. Statistical analysis: K.F., R.B., P.S.W. Review and interpretation of data: all authors. Drafting the manuscript: R.B., P.S.W. Critical revision of manuscript for important intellectual content: all authors. Study supervision: P.S.W.

Corresponding author

Correspondence to Philipp S. Wild.

Ethics declarations

Ethics approval and consent to participate

The Gutenberg COVID-19 Study was approved by the local ethics committee of the “Landesärztekammer Rheinland-Pfalz” (reference no.: 2018–13720). Participating individuals provided a written informed consent before study enrolment. All study procedures were conducted in accordance with Good Epidemiological Practice and the guidelines of the Declaration of Helsinki.

Consent for publication

Not applicable.

Competing interests

Outside the submitted work, P.S.W. reports grants from Bayer AG, non-financial grants from Philips Medical Systems, grants and consulting fees from Boehringer Ingelheim, grants and consulting fees from Novartis Pharma, grants and consulting fees from Sanofi-Aventis, grants, consulting and lecturing fees from Bayer Health Care, grants and consulting fees from Daiichi Sankyo Europe, lecturing fees from Pfizer Pharma, lecturing fees from Bristol Myers Squibb, consulting fees from Astra Zeneca, consulting fees and non-financial support from Diasorin and non-financial support from I.E.M. P.S.W is PI of the German Center for Cardiovascular Research (DZHK) and principal investigator of the DIASyM research core (BMBF DIASyM research core (BMBF 161L0217A). J.H.P received funding for lecturing by Bayer AG and Boehringer Ingelheim outside the topic of this work. The remaining authors report no conflict of interest.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Below is the link to the electronic supplementary material.

Supplementary Material 1

Rights and permissions

Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Baumkötter, R., Yilmaz, S., Zahn, D. et al. Protective behavior and SARS-CoV-2 infection risk in the population – Results from the Gutenberg COVID-19 study. BMC Public Health 22, 1993 (2022). https://doi.org/10.1186/s12889-022-14310-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1186/s12889-022-14310-6

Medical Subject Headings (MeSH)

BMC Public Health

ISSN: 1471-2458

Contact us